IMPORTANT: Updated Interim Clinical Considerations for use of COVID-19 Vaccines in the United States

Oakland County, Michigan sent this bulletin at 09/22/2023 03:13 PM EDT

This email is being sent to VFC, Non-VFC and Covid-19 Providers in Oakland County, Michigan by the Oakland County Health Division (OCHD) Immunization Action Plan (IAP)

mdhhs

Dear Immunization Partners,

Please share the following information with staff and colleagues.

On September 15, 2023, the Centers for Disease Control and Prevention (CDC) updated the Interim Clinical Considerations for use of COVID-19 Vaccines in the United States.

Summary of recent changes:

  • Recommendations for use of the 2023–­2024 formulations of Moderna COVID-19 Vaccine and Pfizer-BioNTech COVID-19 Vaccine:
    • Everyone ages 5 years and older is recommended to receive 1 dose of updated (2023–­2024 Formula) mRNA COVID-19 vaccine
    • Children ages 6 months through 4 years
      • Initial vaccination: should receive either 2 doses of updated (2023­–2024 Formula) Moderna or 3 doses of updated (2023–­2024 Formula) Pfizer-BioNTech COVID-19 vaccine
      • Received previous mRNA doses: need 1 or 2 doses of updated (2023–­2024 Formula) Moderna or updated (2023­–­2024 Formula) Pfizer-BioNTech COVID-19 vaccine, depending on the number of prior doses
    • People who are moderately or severely immunocompromised
      • Initial vaccination: should receive a 3-dose series of updated (2023–­2024 Formula) Moderna or updated (2023–­2024 Formula) Pfizer-BioNTech COVID-19 vaccine
      • Received previous mRNA doses: need 1 or 2 doses of updated (2023­–2024 Formula) Moderna or updated (2023–­2024 Formula) Pfizer-BioNTech COVID-19 vaccine, depending on the number of prior doses
      • May receive 1 or more additional updated (2023–­­2024 Formula) mRNA COVID-19 vaccine doses
    • Bivalent mRNA COVID-19 vaccines are no longer recommended or authorized for use in the United States
  • Updated guidance for COVID-19 vaccination and myocarditis or pericarditis
  • Updated guidance for COVID-19 vaccination and Multisystem Inflammatory Syndrome (MIS) in children (MIS-C) and in adults (MIS-A)
  • Reorganization and consolidation of sections on contraindications and precautions, including allergic reactions to COVID-19 vaccines
  • Vaccine administration errors and deviations was moved from Appendix C to Appendix B.

The Interim Clinical Considerations inform healthcare professionals and public health officials on the use of the COVID-19 vaccines. MDHHS strongly encourages providers to bookmark this resource and refer to it for additional details.

CDC recommends that everyone ages 6 months and older stay up to date with the COVID-19 vaccine to prevent infection.

Thank you for all you do.

Oakland County Health Division, Immunization Action Plan